Rite Aid Says Elixir Buyer On Hook For $225M In Liabilities
By Clara Geoghegan · June 3, 2024, 5:42 PM EDT
Rite Aid alleged the buyer of its prescription benefits subsidiary is trying to dodge $225 million of liabilities that were part of the sale closed in February, and asked a New...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login